| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/20/2005 | CN1642942A Method for manufacture of sertindole |
| 07/20/2005 | CN1642939A Pyridinoylpiperidines as 5-HTLF agonists |
| 07/20/2005 | CN1642938A New compounds |
| 07/20/2005 | CN1642933A Cyclic hemiacetal derivative and use thereof |
| 07/20/2005 | CN1642929A Kappa-opioid receptor agonist comprising 2-phenylbenzothiazoline derivative |
| 07/20/2005 | CN1642927A Cyclic amides |
| 07/20/2005 | CN1642924A Anxiolytic agents with reduced sedative and ataxic effects |
| 07/20/2005 | CN1642918A Novel hererocyclic compound and preparation thereof and medicine composition containing same and use thereof in medicine |
| 07/20/2005 | CN1642916A Preparation of N1-(2'-pyridyl)-1, 2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines |
| 07/20/2005 | CN1642915A Benzamide derivatives useful as histone deacetylase inhibitors |
| 07/20/2005 | CN1642912A Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642911A Phthalimido derivatives as inhibitors of monoamine oxidase B |
| 07/20/2005 | CN1642907A Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642580A Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| 07/20/2005 | CN1642577A Preparation comprising buprenorphine |
| 07/20/2005 | CN1642576A Absorption enhancing agent |
| 07/20/2005 | CN1642573A Combination of an aldosterone receptor antagonist and a fibric acid derivative |
| 07/20/2005 | CN1642572A Remedy for glioblastoma |
| 07/20/2005 | CN1642566A Chimeric hybrid analgesics |
| 07/20/2005 | CN1642565A Process for producing fat composition containing hydrophobic components of glycyrrhiza |
| 07/20/2005 | CN1642558A Theraputic methods and uses of sapogenins and their derivatives |
| 07/20/2005 | CN1642557A Combination of an aldosterone receptor antagonist and nicotinic acid or a nicotinic acid derivative |
| 07/20/2005 | CN1642556A Combination of an aldosterone receptor antagonist and a bile acid sequestering agent |
| 07/20/2005 | CN1642555A Statin therapy for enhancing cognitive maintenance |
| 07/20/2005 | CN1642551A Inhibitors of histone deacetylase |
| 07/20/2005 | CN1642549A Pharmaceutical compositions comprising 2-(4-ethoxy-phenyl)-3-(4-methanesulfonyl-phenyl)-pyrazolo'1, 5-bipyridazine in nanoparticulate form |
| 07/20/2005 | CN1642547A Pharmaceutical composition and method for treating disorders of the central nervous system |
| 07/20/2005 | CN1642545A Time-resolved fluorescence assay for the detection of multimeric forms ofA-beta(beta) or other aggregating polypeptides |
| 07/20/2005 | CN1642541A Method for treating cognitive disorders |
| 07/20/2005 | CN1642537A Ibuprofen solution for hard shell capsules |
| 07/20/2005 | CN1642532A Sustained release formulation of tramadol |
| 07/20/2005 | CN1642529A Matrix for sustained, invariant and independent release of active compounds |
| 07/20/2005 | CN1642528A Stable salts of O-acetylsalicylic acid containing basic amino acids II |
| 07/20/2005 | CN1640877A Novel spiro compounds |
| 07/20/2005 | CN1640462A Drink of Chinese angelica and read-rooted salvia root |
| 07/20/2005 | CN1640452A Use of manchurian tuber gourd fruit extract for preparing analgesic, anti-inflammatory and/or anti-allergic medicine |
| 07/20/2005 | CN1640443A Rhizome gastrodiae preparation and its preparing method |
| 07/20/2005 | CN1640435A Beta-cyclodextrin and polyoxyethylenated castor oil for preparing injection liquid for restoring conscious ness and its preparing method |
| 07/20/2005 | CN1640434A Chinese medicine composition with drug-dropping action, and its preparing method and quality control method |
| 07/20/2005 | CN1640431A Sobering-up shortbread |
| 07/20/2005 | CN1640426A Biological energy reinforced agent-sheep kidney concentrated liquor |
| 07/20/2005 | CN1640425A Effective place of polygala root and its use |
| 07/20/2005 | CN1640424A Drug-dropping medicine and its preparing method |
| 07/20/2005 | CN1640423A Pain-dispersing emplastrum |
| 07/20/2005 | CN1640410A Helicid capsule agent |
| 07/20/2005 | CN1640406A Drug-dropping and intelligence-promoting medicine using ocotillol as effective component, and its preparing method and use |
| 07/20/2005 | CN1640402A Stable naloxone powder for injection |
| 07/20/2005 | CN1640399A Use of acetylchloinesterase inhibitor for preparing medicine for treating parkinson's disease |
| 07/20/2005 | CN1211661C Method of detection of amyloidogenic proteins |
| 07/20/2005 | CN1211385C Bicyclic imidazo-5-yl-amine derivs. |
| 07/20/2005 | CN1211383C Process for making substituted 8-arylquinolinium benzenesulfonate |
| 07/20/2005 | CN1211374C Heterocyclic derivative, its preparation method and medicine compositioncontaining them |
| 07/20/2005 | CN1211368C Amorphous torasemide modification |
| 07/20/2005 | CN1211353C Unsaturated hydroximic acid derivatives as PARP inhibitors |
| 07/20/2005 | CN1211351C Alpha-amino acid amides, prepn. thereof and the therapeutic use thereof |
| 07/20/2005 | CN1211116C Medicine for treating sympthetic nerve disorder |
| 07/20/2005 | CN1211100C Compound composite medicine for giving up drug-addiction |
| 07/20/2005 | CN1211098C Use of centella general glucoside for resisting depression |
| 07/20/2005 | CN1211085C Compositions having improved stability |
| 07/19/2005 | US6919470 Aryl and heteroaryl sulfonates |
| 07/19/2005 | US6919438 Comprises viral expression vector coding envelope protein domains for use as gene therapeutic tool in the treatment of autoimmune diseases |
| 07/19/2005 | US6919379 Compounds useful in reflux disease |
| 07/19/2005 | US6919378 Pharmaceutical solutions of modafinil compounds |
| 07/19/2005 | US6919377 Cyclohexylamine derivative as subtype selective NMDA receptor antagonists |
| 07/19/2005 | US6919367 Substituted thioacetamides |
| 07/19/2005 | US6919363 Central nervous system disorders; antiischemic agents; analgesics |
| 07/19/2005 | US6919362 For use as hypoglycaemic and hypolipidaemic agents |
| 07/19/2005 | US6919360 Benzisothiazolyl-substituted aminomethyl chromanes for treating diseases of the central nervous system |
| 07/19/2005 | US6919359 Azabicyclic-substituted-heteroaryl compounds for the treatment of disease |
| 07/19/2005 | US6919355 Amide derivatives as NMDA receptor antagonists |
| 07/19/2005 | US6919354 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 07/19/2005 | US6919353 Enzyme inhibitors of phosphordiesterase 4 having minimal side effects; antiinflammatory agents; antiallergens; asthma; neurodegenerative disorders; antidiabetic agents; pain; anti-tumor, -carcinogenic and -arthritic agents |
| 07/19/2005 | US6919347 Antidiabetic agents; antiinflammatory agents; analgesics; antiallergens |
| 07/19/2005 | US6919345 Sulfonate substituted pyrazol pyridine derivatives |
| 07/19/2005 | US6919343 N-biphenyl(substituted methyl) aminocycloalkane-carboxamide derivatives |
| 07/19/2005 | US6919340 Kinase moderators; controlling gene expression; immunosuppressants; autoimmune disease; rheumatic disorders; skin disorders; antitumor agents; anticancer agents |
| 07/19/2005 | US6919334 Antidepressant azaheterocyclymethyl derivatives of 4,5-dihydroimidazo[1,4,5-de][1,4]benzoxazine |
| 07/19/2005 | US6919332 Enzyme inhibitors such as 5-(2-Methoxy-ethyl)-5-(4-(1-pyridin -3-yl-1H-indazol-5-yloxy)-phenoxy)-pyrimidine-2,4,6-trione, used as antiinflammatory and anticarcinogenic agents |
| 07/19/2005 | US6919330 Formulations of drugs |
| 07/19/2005 | US6919307 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 07/19/2005 | US6919094 Composition of medicine for treating headache disease and process of preparation and uses thereof |
| 07/19/2005 | US6919075 Bacteriophage displaying aβ epitopes and method of use |
| 07/19/2005 | CA2348017C Anticonvulsant derivatives useful in treating alcohol dependency, addiction and abuse |
| 07/14/2005 | WO2005063759A1 PROCESS FOR PREPARING PYRROLO[2, 1-c] [1, 4] BENZODIAZEPINE HYBRIDS |
| 07/14/2005 | WO2005063758A1 C2-FLUORO PYRROLO[2,1-c][1,4]BENZODIAZEPINE DIMERS |
| 07/14/2005 | WO2005063738A1 Novel 2-heteroaryl-substituted benzimidazole derivative |
| 07/14/2005 | WO2005063725A1 Phenylpropanoic acid derivatives |
| 07/14/2005 | WO2005063704A1 Azetidine ring compounds and drugs comprising the same |
| 07/14/2005 | WO2005063294A1 Inhibitor for the formation of ϝ-secretase complex |
| 07/14/2005 | WO2005063241A1 Preventive and/or therapeutic agent for disease in which mitochondrial benzodiazepine receptor participates |
| 07/14/2005 | WO2005063236A1 Intranasal formulation of rotigotine |
| 07/14/2005 | WO2005037785A3 Derivatives of n-[phenyl(pyrrolidine-2-yl)methyl]benzamide and n-[(azepan-2-yl)phenylmethyl]benzamide, preparation method thereof and application of same in therapeutics |
| 07/14/2005 | WO2005037781A3 Derivatives of n-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics |
| 07/14/2005 | WO2005023198A3 Modafinil compositions |
| 07/14/2005 | WO2004103394A3 Method and compositions for nerve regeneration |
| 07/14/2005 | WO2003059294A3 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor |
| 07/14/2005 | WO2003029424A3 Novel proteins and nucleic acids encoding same |
| 07/14/2005 | US20050155089 Transport protein for use in identifying modulators for prevention and treatment of inflammation, cardiovascular, neurological, reproductive and developmental disorders |
| 07/14/2005 | US20050155087 Method of screening compounds |
| 07/14/2005 | US20050154230 Urea derivatives |